These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10088904)

  • 1. First rotavirus vaccine licensed: is there really a need?
    Glass RI; Bresee JS; Parashar UD; Holman RC; Gentsch JR
    Acta Paediatr Suppl; 1999 Jan; 88(426):2-8. PubMed ID: 10088904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1999 Mar; 48(RR-2):1-20. PubMed ID: 10219046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of a rotavirus immunization program for the United States.
    Tucker AW; Haddix AC; Bresee JS; Holman RC; Parashar UD; Glass RI
    JAMA; 1998 May; 279(17):1371-6. PubMed ID: 9582045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rotavirus vaccine.
    Offit PA
    J Clin Virol; 1998 Dec; 11(3):155-9. PubMed ID: 9949951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Parashar UD; Alexander JP; Glass RI;
    MMWR Recomm Rep; 2006 Aug; 55(RR-12):1-13. PubMed ID: 16902398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.
    Grimwood K; Lambert SB; Milne RJ
    Paediatr Drugs; 2010 Aug; 12(4):235-56. PubMed ID: 20593908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of rotavirus vaccines.
    Wang CM; Chen SC; Chen KT
    World J Pediatr; 2015 Nov; 11(4):300-8. PubMed ID: 26454434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study.
    Ai CE; Steele M; Lopman B
    PLoS One; 2020; 15(2):e0228942. PubMed ID: 32059029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden.
    Glass RI; Kilgore PE; Holman RC; Jin S; Smith JC; Woods PA; Clarke MJ; Ho MS; Gentsch JR
    J Infect Dis; 1996 Sep; 174 Suppl 1():S5-11. PubMed ID: 8752284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.
    Lanata CF; Black RE; del Aguila R; Gil A; Verastegui H; Gerna G; Flores J; Kapikian AZ; Andre FE
    J Infect Dis; 1989 Mar; 159(3):452-9. PubMed ID: 2536789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J; Koskenniemi E; Pang XL; Vesikari T
    Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The control of rotavirus gastroenteritis in the United States.
    Glass RI; Parashar U; Patel M; Tate J; Jiang B; Gentsch J
    Trans Am Clin Climatol Assoc; 2012; 123():36-52; discussion 53. PubMed ID: 23303967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.
    Plosker GL
    BioDrugs; 2010 Dec; 24(6):411-4. PubMed ID: 21043548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design.
    Zhen SS; Li Y; Wang SM; Zhang XJ; Hao ZY; Chen Y; Wang D; Zhang YH; Zhang ZY; Ma JC; Zhou P; Zhang Z; Jiang ZW; Zhao YL; Wang XY
    Emerg Microbes Infect; 2015 Oct; 4(10):e64. PubMed ID: 26576341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.